Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cost-effectiveness of allergen immunotherapy versus symptomatic medication in Chinese children with moderate to severe allergic rhinitis
ChiCTR-OPN-15006592Phase 4Recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of alutard-sq in allergic rhinitis (AR) (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoints: Treatment costs on allergic rhinitis, Medications on allergic rhinitis and 7 more. Started Jun 2015; status: recruiting.
02
Drugs
alutard-sq
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR-OPN-15006592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006592.